Donnet A, Harle J R, Dumont J C, Alif Cherif A
Clinique de Neurologie, CHU Timone, Marseille, France.
Biomed Pharmacother. 1991;45(10):461-2. doi: 10.1016/0753-3322(91)90048-x.
Neuroleptic malignant syndrome (NMS) associated with metoclopramide is rare. NMS probably results from neuroleptic-induced dopamine receptor blockade. We describe a case and have found only seven reports of metoclopramide-induced NMS in the literature.
与甲氧氯普胺相关的抗精神病药恶性综合征(NMS)很罕见。NMS可能是由抗精神病药引起的多巴胺受体阻断所致。我们报告一例病例,并且在文献中仅发现七例甲氧氯普胺诱发NMS的报道。